[3P] Neurodegenerative Disorders

[3P-225] A treatment strategy for ALS neuromuscular junction degeneration using human mesenchymal stem cells

*Hiroshi Nishimune^1,2, Yomna Badawi², Takashi Matsuda², Sudheer Tungtur², Tomohiro Tanaka², Rupal Soder³, Kleiton Silva⁵, Tadashi Yoshida⁵, Richard Barohn⁴ (1.Tokyo Metropolitan Institute of Gerontology, 2.Dept Anatomy and Cell Biology, Univ Kansas Sch Medicine, Kansas City, USA, 3.Midwest Stem Cell Therapy Center, Univ Kansas Medical Center, Kansas City, USA, 4.Dept Neurology, Univ Kansas Sch Medicine, Kansas City, USA, 5.Tulane Univ. Heart & Vascular Institute, New Orleans, USA)